A new study has identified key factors that indicate when patients with acute myeloid leukaemia (AML) are unlikely to respond to venetoclax.
Researchers in Colorado, USA, found that monocytic disease was linked to poor outcomes, especially if they...
1 month ago
Well, what an uplifting event we had in Glasgow - thank you for the positive feedback! It was truly inspiring to witness the breadth and depth of science and progress on display. The commitment of our research teams and the mentoring and developme...
1 month ago
